Relay Therapeutics, Inc.
RLAY • NASDAQ
Relay Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanjiv K. Patel, with a market cap of $1.7B.
CEOSanjiv K. Patel
Next Earnings
Upcoming earnings announcement for Relay Therapeutics, Inc.
Date
Monday, May 4, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.35
Revenue Estimate
$8.2M
Earnings History
Past 12 earnings reports for Relay Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | -$0.32Est: -$0.39 | +17.9% | $7.0MEst: $8.6M | -18.1% | — |
| Nov 6, 2025 | Q3 2025 | -$0.43Est: -$0.41 | -4.9% | -Est: $332.0K | -100.0% |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.41Est: -$0.48 | +14.6% | $677.0KEst: $245.0K | +176.3% | 10-Q |
| May 5, 2025 | Q1 2025 | -$0.46Est: -$0.51 | +9.8% | $7.7MEst: $11.1K | +69017.9% | 10-Q |
| Feb 26, 2025 | Q4 2024 | -$0.45Est: -$0.55 | +18.2% | -Est: $5.5M | -100.0% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.63Est: -$0.77 | +18.2% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.69Est: -$0.73 | +5.5% | -Est: $80.0K | -100.0% | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.62Est: -$0.71 | +12.7% | $10.0MEst: $90.0K | +11018.9% | 10-Q |
| Feb 22, 2024 | Q4 2023 | -$0.67Est: -$0.73 | +8.2% | -Est: $130.0K | -100.0% | 10-K |
| Nov 2, 2023 | Q3 2023 | -$0.54Est: -$0.83 | +34.9% | $25.2M | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.81Est: -$0.81 | 0.0% | $119.0KEst: $750.0K | -84.1% | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.78Est: -$0.69 | -13.0% | $226.0KEst: $210.0K | +7.6% | 10-Q |